The USPSTF recently issued a Draft Grade A recommendation that all at-risk patients be offered pre-exposure prophylaxis to prevent the transmission of HIV. This multi drug, single pill regimen can lower risk of HIV and potentially prevent lifelong burden of disease. While only a draft recommendation, the USPSTF expects, after stakeholder comment, to continue to support an A recommendation to offer for all patients who are increased risk.

There are various treatment options for patients with acute sciatica. Choosing the best option should be tailored to the specific needs of the patient, and when possible, include early recommendation for physical therapy (PT). In this episode we review research on use of PT for treatment of sciatica and discuss how you can incorporate PT recommendations into patient care.

This podcast series will provide you with on the go learning covering the key points about GLP-1 receptor agonists (GLP-1 RAs). Dr. Michelle Magee will focus on barriers that patients may face to starting a GLP-1 RA and common questions that emerge in patient teaching. Cardiologist Ty Gluckman will take a deep dive into the cardiology benefits and indications for GLP-1 RAs. A FAQ session with Dr. Richard Pratley will answer Pri-Med learner questions about GLP-1 RAs.

Join us as we discuss data from the National Longitudinal Study of Adolescent to Adult Health examining how family relationships impact depression.

In this episode, we will review a recent publication examining how the polypill might lower atherosclerotic cardiovascular disease (ASCVD) risk in the general population.

In this podcast, cardiologist Ty Gluckman will take a deep dive into the cardiology benefits of glucagon like peptide-1 receptor agonists (GLP-1 RA). He will review the clinical trial data which has resulted in GLP-1 RA incorporation into guidelines, which address patients who have both diabetes and atherosclerotic cardiovascular disease. Dr. Gluckman will bring the perspective of a cardiologist into the discussion of these agents with emerging significance in cardiovascular risk reduction.

Join pulmonologist Dr. Chris Fanta as he discusses acute exacerbations and COPD. The podcast begins with a typical case presentation seen in primary care which highlights the experience of acute exacerbations of COPD. Next, Dr. Fanta discusses the impact of COPD on the lives of patients and, lastly, discusses how COPD is treatable and, to some extent, preventable in an outpatient setting. Please note that any data, indications, and guidelines presented in this activity are current as of the recording 9/1/2020 and they are subject to change as new information is published.

Join us as we review the United States Preventive Services Task Force’s (USPSTF) recently published draft recommendation statement on colorectal cancer (CRC) screening and the implications it has for primary care practice and your patients.

Review the latest research on the impact of Non-Nutritive Sweeteners (NNS) on mortality, disease, and intermediate outcomes like microbiome and gut hormones.

Join pulmonologist Emily Wan, MD as she answers the most pressing questions regarding the management of COPD. In this podcast, Dr. Wan will discuss topics such as when to step-up and step-down therapy, the role of eosinophil count in acute exacerbations, strategies for educating patients on correct inhaler technique (hint – don’t forget about the pharmacist!), how COVID-19 has impacted the management of COPD, and more.

Heartburn is a frequent complaint in primary care practices. The etiology is broad, from reflux to H. pylori infection and PUD. While many clinicians treat symptomatically, this may not lead to patient satisfaction. A recent network meta-analysis published in The BMJ, concluded that a ‘test and treat’ approach resulted in the lowest reports for patients to remain symptomatic at follow-up.

Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults 75 years and older. During this episode we will review recent studies on the use of statins in elderly patients and discuss how to consider this data in your clinical practice.